Literature DB >> 19638151

What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?

George Garratty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19638151     DOI： 10.1111/j.1537-2995.2009.02216.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

Review 1.  RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Authors:  Jenny M Despotovic; Michele P Lambert; Jay H Herman; Terry B Gernsheimer; Keith R McCrae; Michael D Tarantino; James B Bussel
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

2.  Rare problems with RhD immunoglobulin for postnatal prophylaxis after large fetomaternal haemorrhage.

Authors:  Amber Biscoe; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2015-08-21

Review 3.  Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives.

Authors:  Tony Zitek; Luke Weber; Dominique Pinzon; Nicole Warren
Journal:  Open Access Emerg Med       Date:  2022-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.